vidaza
bristol-myers squibb pharma eeig - asatsitidiin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastilised ained - vidaza is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with: intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification. vidaza is indicated for the treatment of adult patients aged 65 years or older who are not eligible for hsct with aml with >30% marrow blasts according to the who classification.
upcard
vétoquinol sa - torasemiid veevaba - sulfoonamiidide, tavaline, suur-lae-diureetikumid - koerad - kliiniliste tunnuste, kaasa arvatud ödeem ja efusioon, raviks on koertel südame paispuudulikkus.
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastilised ained - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
zantac 75 õhukese polümeerikattega tablett
glaxosmithkline export ltd - ranitidiin - õhukese polümeerikattega tablett - 75mg 24tk; 75mg 12tk
raniberl 300 mg õhukese polümeerikattega tablett
berlin-chemie ag - ranitidiin - õhukese polümeerikattega tablett - 300mg 50tk; 300mg 20tk
zantac õhukese polümeerikattega tablett
glaxosmithkline export ltd - ranitidiin - õhukese polümeerikattega tablett - 150mg 60tk; 150mg 20tk
raniberl 150 õhukese polümeerikattega tablett
berlin-chemie ag - ranitidiin - õhukese polümeerikattega tablett - 150mg 50tk; 150mg 20tk
arnetin süste-/infusioonilahus
medochemie limited - ranitidiin - süste-/infusioonilahus - 25mg 1ml 2ml 100tk; 25mg 1ml 2ml 5tk
ranisan 150 mg õhukese polümeerikattega tablett
pro.med.cs praha a.s. - ranitidiin - õhukese polümeerikattega tablett - 150mg 20tk; 150mg 60tk
ranisan 75mg õhukese polümeerikattega tablett
pro.med.cs praha a.s. - ranitidiin - õhukese polümeerikattega tablett - 75mg 20tk; 75mg 10tk